All News

January, 2023
Biocom highlights backgrounds of Catalyst Award winners including CEO Hanadie YousefLearn More »

December, 2022
Longevity Technology Spotlights the Early Beginnings and Future Vision of Juvena TherapeuticsLearn More »
July, 2022
CSO and Co-Founder Dr. Jeremy O’Connell presents at FASEB Industry Panel Jul. 2022Learn More »
November, 2021
CIRM Awards Juvena a $3.9M TRAN1 Grant to Advance JUV-161 for Myotonic Dystrophy Type 1 (DM1)Learn More »

August, 2021
CEO Dr. Hanadie Yousef Interviewed for Translating Aging Podcast, “The Cures Within Us”Learn More »

February, 2021
Juvena Therapeutics Presents at the International Longevity Alliance Conference Workshop Feb 2021Learn More »
February, 2020
Juvena Therapeutics Interviewed– Embryonic Proteins for Tissue Regeneration- Jan 2020Learn More »
January, 2020
Juvena Therapeutics Listed as 1 of 3 Ground Breaking Longevity StartupsLearn More »
November, 2019
CEO Dr. Hanadie Yousef Presents at UC Berkeley’s Slam Seminar Series Nov. 2019Learn More »
Press Releases & News Articles
January, 2023
Biocom highlights backgrounds of Catalyst Award winners including CEO Hanadie YousefRead More »
December, 2022
Longevity Technology Spotlights the Early Beginnings and Future Vision of Juvena TherapeuticsRead More »
November, 2021
CIRM Awards Juvena a $3.9M TRAN1 Grant to Advance JUV-161 for Myotonic Dystrophy Type 1 (DM1)Read More »
February, 2020
Juvena Therapeutics Interviewed– Embryonic Proteins for Tissue Regeneration- Jan 2020Read More »
Videos
